Article
Long-term NAD+ supplementation prevents the progression of age-related hearing loss in mice
2022-08-26
Abstract excerpt
<h4>ABSTRACT</h4> Age-related hearing loss (ARHL) is the most common sensory disability associated with human aging. Yet, there are no approved measures for preventing or treating this debilitating condition. With its slow progression, continuous and safe approaches are critical for ARHL treatment. Nicotinamide Riboside (NR), a NAD+ precursor, is well tolerated even for long-term use and is already shown effectiv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc7d7b67-615c-54f5-a635-fe995ffbfcc9
- DOI
- 10.1101/2022.08.25.505332
